Deepak Bhatt, MD: Impact of COVID-19 on Clinical Trials in Cardiology

Podcast

Deepak Bhatt, MD, offers perspective on how the ongoing pandemic has impacted clinical trials in the cardiovascular space.

This episode of the Practical Cardiology Podcast features an interview with Deepak Bhatt, MD, MPH, executive director of interventional cardiovascular programs at Brigham and Women’s Hospital and professor of medicine at Harvard Medical School, discussing clinical trials in cardiology during the ongoing pandemic.

The subject of the current interview is an article penned by Bhatt and other cardiologists addressing the impact the ongoing coronavirus disease 2019 (COVID-19) pandemic has had on cardiovascular trials in the United States, titled “The Landscape of Cardiovascular Clinical Trials in the United States Initiated Before and During COVID-19”.


A leading trialist involved in major trials including REDUCE-IT and THEMIS, Bhatt offers perspective on data from a professional and personal perspective on how the pandemic has, is, and will continue to affect clinical trials, with the ripple causing disruptions in treatment pipelines and the treatment of patients.

Recent Videos
Brendon Neuen, MBBS, PhD | Credit: X.com
A panel of 5 cardiovascular experts
Video 5 - "Real-World Insights: Navigating Cardiac Myosin inhibitors in Practice" - Featuring 1 KOL
A panel of 5 cardiovascular experts
A panel of 5 cardiovascular experts
Video 4 - "Mavacamten in oHCM: Navigating the REMS Program for Safe, Optimal Outcomes "
Video 3 - "Aligning With 2023 ESC Guidelines in oHCM Treatment"
Robert Rosenson, MD | Credit: Cura Foundation
A panel of 5 cardiovascular experts
A panel of 5 cardiovascular experts
© 2024 MJH Life Sciences

All rights reserved.